A forward-looking Group
Interview with Roch Doliveux, Chairman of the Supervisory board.
What conclusions have you drawn from the Transformation plan that was wrapped up in 2022?
Roch Doliveux : First and foremost, the Transformation plan has been a great success, one we can all be proud of. It was ambitious, and the teams rallied to achieve its objectives. I’d like to take this opportunity to congratulate everyone here for their contribution. Thanks to numerous achievements, we have created the necessary financial leeway to invest in our future. As a result, we have been able to acquire new molecules to replace those with patents set to expire in the next ten years. We have also been able to give our flagship brand, Eau Thermale Avène, more resources to accelerate and regain market share.
Finally, this plan has enabled us to make progress on crucial issues, including digital technologies and our environmental footprint. But our transformation is not over yet.
What challenges remain?
R.D. : I think one of the biggest challenges for our Group is achieving the right balance between preserving our strong culture, stimulating innovation, and integrating new talent with kindness and genuine interest. This is absolutely essential to boost our competitiveness. Our environment and our competitors are constantly evolving, and are doing so increasingly quickly. If we do not provide ourselves with the means to gather a quicker pace and become more agile than our competitors, our positions will crumble and this will weaken our longevity. We can also make further progress on our “patient and customer” thrust and on the materialization of our Purpose: caring for the patients and consumers for whom our drugs and dermo-cosmetics are intended. My wish is that each patient who suffers from any of the diseases targeted by one of our drugs, that each person who needs a dermo-cosmetic product for his or her skin condition, has access to the right product.
Where should the Group focus its efforts in the short term?
R.D. : It is essential that we continue our efforts to build our competitive advantages, for example in innovation and medical care. We must develop our competitiveness, maximize the potential of every individual. We must care for others, our regions and our Planet. We should rejoice in our successes and in the impact of the dividends paid to the Pierre Fabre Foundation so that it may continue developing effective and courageous actions.